Dengue cases lead to an increase in PhilHealth payments in Eastern Visayas

Posted by Takards on September 14, 2024 with No comments


TACLOBAN CITY – The Philippine Health Insurance Corporation (PhilHealth) in Eastern Visayas has noted a substantial rise in payments to healthcare facilities due to a spike in dengue cases in Region 8. According to Asisclo Militante Jr., the field operations chief for PhilHealth-Eastern Visayas, the agency had allocated P68.01 million to cover the expenses of 6,052 dengue patients by the first week of September.

This amount has already exceeded last year’s total payout of P53.90 million, which covered 5,878 dengue patients. Dengue treatment is part of PhilHealth’s benefit package, providing support to both members and non-members.

Dengue patients admitted to hospitals can receive P13,000 in compensation from PhilHealth, representing roughly a 30 percent increase from the P10,000 provided in previous years.

“Dengue treatment has been included in the PhilHealth package as long as the patients are admitted to a healthcare facility,” Militante stated in an interview on September 10.

Leyte province, including Tacloban City, reported the highest number of dengue cases in the region, with 4,633 cases from January 1 to August 31 this year. It was followed by Samar with 2,832 cases, Southern Leyte with 1,643, Eastern Samar with 893, Northern Samar with 576, and Biliran with 230.

Samar also recorded the most dengue-related deaths, totaling 11, followed by Leyte with five, Eastern Samar with three, Northern Samar with two, and Southern Leyte with one. No fatalities were reported in Biliran.

The increase in dengue cases in Eastern Visayas has been linked to the heavy rainfall in the region over the past weeks.

Dengue is caused by the Aedes aegypti mosquitoes. The infection leads to a severe flu-like illness, which is frequently accompanied by a significant drop in the affected individual's platelet count.

Other symptoms include intense headaches, pain behind the eyes, widespread body aches, nausea, vomiting, and swollen glands or rashes.


0 comments:

Post a Comment